Literature DB >> 24041461

Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation.

João Soeiro Teodoro1, Filipe Valente Duarte, Ana Patrícia Gomes, Ana Teresa Varela, Francisco Manuel Peixoto, Anabela Pinto Rolo, Carlos Marques Palmeira.   

Abstract

Berberine is an isoquinoline alkaloid with anti-diabetic properties. Despite the central role of liver and thus hepatic mitochondria in whole-body metabolism, berberine effects on hepatic mitochondrial function in an obesity model are still unknown. Here, we demonstrate that berberine treatment recovers mitochondrial efficiency when altered by a high-fat feeding. Mitochondria isolated from the liver of high-fat fed rats exhibited decreased capacity to accumulate calcium and impaired oxidative phosphorylation (OXPHOS) capacity, as shown by impaired mitochondrial membrane potential, oxygen consumption and cellular ATP levels. Interestingly, the recovery of mitochondrial function by berberine was associated with an increased activity of the mitochondrial sirtuin 3 (SirT3). In conclusion, berberine potent protective effects against metabolic syndrome may rely on increasing mitochondrial SirT3 activity, normalizing mitochondrial function and preventing a state of energetic deficit caused by impaired OXPHOS.
© 2013.

Entities:  

Keywords:  ACC; AMP-activated protein kinase; AMPK; BBR; Berberine; Ctl; FAME; FCCP; FFA; HFD; Liver bioenergetics; Mitochondrial function; NAFLD; OXPHOS; Obesity; RCR; ROS; Respiratory Control Ratio; SirT3; T2D; TPP+; acetyl-CoA carboxylase; berberine-supplemented HFD group; carbonylcyanide-P-trifluoromethoxyphenylhydrazon; control low fat diet-fed group; fatty acid methyl ester; free fatty acids; high fat diet-fed group; non-alcoholic fatty liver disease; oxidative phosphorylation; reactive oxygen species; sirtuin 3; tetraphenylphosphonium; type II diabetes

Mesh:

Substances:

Year:  2013        PMID: 24041461     DOI: 10.1016/j.mito.2013.09.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  33 in total

Review 1.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation.

Authors:  Eirini Pantazi; Mohamed Bejaoui; Mohamed Amine Zaouali; Emma Folch-Puy; Anabela Pinto Rolo; Arnau Panisello; Carlos Marques Palmeira; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 3.  A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.

Authors:  Raffaella Crescenzo; Francesca Bianco; Arianna Mazzoli; Antonia Giacco; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2016-02       Impact factor: 5.614

4.  High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.

Authors:  João S Teodoro; Ana T Varela; Anabela P Rolo; Carlos M Palmeira
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

5.  Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle.

Authors:  E P Taddeo; R C Laker; D S Breen; Y N Akhtar; B M Kenwood; J A Liao; M Zhang; D J Fazakerley; J L Tomsig; T E Harris; S R Keller; J D Chow; K R Lynch; M Chokki; J D Molkentin; N Turner; D E James; Z Yan; K L Hoehn
Journal:  Mol Metab       Date:  2013-11-26       Impact factor: 7.422

Review 6.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

Review 7.  Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.

Authors:  Serena De Matteis; Anna Maria Granato; Roberta Napolitano; Chiara Molinari; Martina Valgiusti; Daniele Santini; Francesco Giuseppe Foschi; Giorgio Ercolani; Umberto Vespasiani Gentilucci; Luca Faloppi; Mario Scartozzi; Giovanni Luca Frassineti; Andrea Casadei Gardini
Journal:  Dig Dis Sci       Date:  2017-05-19       Impact factor: 3.199

8.  Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3.

Authors:  Bingjie Zhang; Yida Pan; Lei Xu; Dehua Tang; Robert Gregory Dorfman; Qian Zhou; Yuyao Yin; Yang Li; Lixing Zhou; Shimin Zhao; Xiaoping Zou; Lei Wang; Mingming Zhang
Journal:  Endocrine       Date:  2018-08-16       Impact factor: 3.633

9.  Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets.

Authors:  Kang-Le Lu; Li-Na Wang; Ding-Dong Zhang; Wen-Bin Liu; Wei-Na Xu
Journal:  Fish Physiol Biochem       Date:  2016-08-06       Impact factor: 2.794

Review 10.  Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Authors:  Agostino Di Ciaula; Salvatore Passarella; Harshitha Shanmugam; Marica Noviello; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.